Skip to content

COVAX expands with World Bank backing

The World Bank approved US$2 billion in financing for COVID-19 vaccines in 17 developing countries as part of a two-year US$12 billion package.

A photo illustration of medicinal syringes used to administer drugs, vaccines and blood transfusions
A photo illustration of medicinal syringes used to administer drugs, vaccines and blood transfusions (AN/Jernej Furman)

WASHINGTON (AN) — The World Bank approved US$2 billion in financing for COVID-19 vaccines in 17 developing countries on Tuesday, part of a two-year US$12 billion package aimed at helping poorer nations strengthen their vaccination systems.

The funding will support COVID-19 vaccinations in Afghanistan, Bangladesh, Cape Verde, Ecuador, El Salvador, Eswatini, Ethiopia, Gambia, Honduras, Ivory Coast, Lebanon, Mongolia, Nepal, Philippines, Rwanda, Tajikistan and Tunisia.

Get full Free+ access with a free subscription

Join now

Already have an account? Log in

Latest